Novavax (NVAX) closed at $9.62 in the latest trading session, marking a -1.23% move from the prior day. The stock exceeded the S&P 500, which registered a loss of 1.51% for the day. Meanwhile, the Dow ...

Proposed acquisition supports the Novartis oncology strategy in hormone receptor positive, human epidermal growth factor receptor two-negative (HR+/HER2-) breast cancer ; The lead ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Novo Nordisk A/S won approval to sell a high-dose version of its blockbuster Wegovy obesity shot in the US, allowing it to offer weight loss closer to that of rival Eli Lilly & Co.’s competing shot ...

Novo Nordisk said on Thursday the U.S. Food and Drug Administration has approved ​a higher dose of its blockbuster ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

A person poses with a dose of Novavax Nuvaxovid COVID-19 vaccine in this illustration picture taken in Schwenksville, Pennsylvania, U.S. October 2, 2025. REUTERS/Hannah Beier/Illustration March 16 ...